ArticleSpringerPlus2014

Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC).

Felix Bremmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.